Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study

Actas Dermosifiliogr. 2024 Apr 4:S0001-7310(24)00282-5. doi: 10.1016/j.ad.2024.04.001. Online ahead of print.NO ABSTRACTPMID:38582299 | DOI:10.1016/j.ad.2024.04.001

Source: Actas Dermo-Sifiliograficas - April 6, 2024 Category: Dermatology Authors: J Naharro Rodr íguez E Bern á Rico F J P érez-Bootello B P érez García Source Type: research